Active Shortage

NAT-ERIBULIN

NATCO PHARMA (CANADA) INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of NAT-ERIBULIN in Canada?

Yes. NAT-ERIBULIN 0.5MG has an active shortage reported to Health Canada (last updated July 22, 2026).

Why is NAT-ERIBULIN not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will NAT-ERIBULIN be available again?

The manufacturer's estimated resolution date is August 31, 2027. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusActive Shortage

Same-ingredient products on file2 products

Expected resolution~11 months remaining (estimate)

Affected strength0.5MG

Last updated2026-07-22

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

HALAVEN

EISAI LIMITED

0.5MG · DIN 02377438

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

ERIBULIN MESYLATE INJECTION

DR REDDY'S LABORATORIES LTD

0.5MG · DIN 02545950

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

Estimated Resolution

2027-08-31

~11 months remaining (estimate)

This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.

DIN

02539136

Strength

0.5MG

Dosage Form

SOLUTION

Route

INTRAVENOUS

Active Ingredient

ERIBULIN MESYLATE

Tier

Unrated

Last Updated

2026-07-22

Reason for Shortage

Disruption of the manufacture of the drug.

Source

View original report on healthproductshortages.ca ↗

Other Products from NATCO PHARMA (CANADA) INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

250MG · DIN 02494132

1MG · DIN 02417855

2.5MG · DIN 02492814

5MG · DIN 02492822

100MG · DIN 02496895

25MG · DIN 02496887